These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 9649304)
41. Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants. Moraitis AN; Giguère V; Thompson CC Mol Cell Biol; 2002 Oct; 22(19):6831-41. PubMed ID: 12215540 [TBL] [Abstract][Full Text] [Related]
42. Characterization of the differential coregulator binding signatures of the Retinoic Acid Receptor subtypes upon (ant)agonist action. Miro Estruch I; Melchers D; Houtman R; de Haan LHJ; Groten JP; Louisse J; Rietjens IMCM Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1195-1206. PubMed ID: 28642153 [TBL] [Abstract][Full Text] [Related]
43. Induction of retinoid resistance in breast cancer cells by overexpression of cJun. Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582 [TBL] [Abstract][Full Text] [Related]
44. Dynamic inhibition of nuclear receptor activation by corepressor binding. Sohn YC; Kim SW; Lee S; Kong YY; Na DS; Lee SK; Lee JW Mol Endocrinol; 2003 Mar; 17(3):366-72. PubMed ID: 12554786 [TBL] [Abstract][Full Text] [Related]
45. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. Klaholz BP; Mitschler A; Moras D J Mol Biol; 2000 Sep; 302(1):155-70. PubMed ID: 10964567 [TBL] [Abstract][Full Text] [Related]
46. The Stat5-RARalpha fusion protein represses transcription and differentiation through interaction with a corepressor complex. Maurer AB; Wichmann C; Gross A; Kunkel H; Heinzel T; Ruthardt M; Groner B; Grez M Blood; 2002 Apr; 99(8):2647-52. PubMed ID: 11929749 [TBL] [Abstract][Full Text] [Related]
47. Recombinant human retinoic acid receptor beta. Binding of synthetic retinoids and transcriptional activation. Lombardo A; Costa E; Chao WR; Toll L; Hobbs PD; Jong L; Lee MO; Pfahl M; Ely KR; Dawson MI J Biol Chem; 1994 Mar; 269(10):7297-303. PubMed ID: 8125944 [TBL] [Abstract][Full Text] [Related]
48. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity. Farooqui M; Franco PJ; Thompson J; Kagechika H; Chandraratna RA; Banaszak L; Wei LN Biochemistry; 2003 Feb; 42(4):971-9. PubMed ID: 12549917 [TBL] [Abstract][Full Text] [Related]
49. Characterization of heterologously expressed recombinant retinoic acid receptors with natural or synthetic retinoids. Kim YW; Sharma RP; Li JK J Biochem Toxicol; 1994 Oct; 9(5):225-34. PubMed ID: 7853357 [TBL] [Abstract][Full Text] [Related]
50. Interactions that determine the assembly of a retinoid X receptor/corepressor complex. Ghosh JC; Yang X; Zhang A; Lambert MH; Li H; Xu HE; Chen JD Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5842-7. PubMed ID: 11972046 [TBL] [Abstract][Full Text] [Related]
52. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Germain P; Iyer J; Zechel C; Gronemeyer H Nature; 2002 Jan; 415(6868):187-92. PubMed ID: 11805839 [TBL] [Abstract][Full Text] [Related]
53. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists. Géhin M; Vivat V; Wurtz JM; Losson R; Chambon P; Moras D; Gronemeyer H Chem Biol; 1999 Aug; 6(8):519-29. PubMed ID: 10421757 [TBL] [Abstract][Full Text] [Related]
54. Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORgamma. Kurebayashi S; Nakajima T; Kim SC; Chang CY; McDonnell DP; Renaud JP; Jetten AM Biochem Biophys Res Commun; 2004 Mar; 315(4):919-27. PubMed ID: 14985100 [TBL] [Abstract][Full Text] [Related]
55. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells. Zhuang Y; Faria TN; Chambon P; Gudas LJ Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409 [TBL] [Abstract][Full Text] [Related]
56. Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor. Nagpal S; Ghosn C; DiSepio D; Molina Y; Sutter M; Klein ES; Chandraratna RA J Biol Chem; 1999 Aug; 274(32):22563-8. PubMed ID: 10428834 [TBL] [Abstract][Full Text] [Related]
57. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. Egea PF; Mitschler A; Rochel N; Ruff M; Chambon P; Moras D EMBO J; 2000 Jun; 19(11):2592-601. PubMed ID: 10835357 [TBL] [Abstract][Full Text] [Related]
58. The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. Mascrez B; Mark M; Dierich A; Ghyselinck NB; Kastner P; Chambon P Development; 1998 Dec; 125(23):4691-707. PubMed ID: 9806918 [TBL] [Abstract][Full Text] [Related]
59. Co-repressor release but not ligand binding is a prerequisite for transcription activation by human retinoid acid receptor alpha ligand-binding domain. Kao HY; Han CC; Komar AA; Evans RM J Biol Chem; 2003 Feb; 278(9):7366-73. PubMed ID: 12468549 [TBL] [Abstract][Full Text] [Related]